If you or someone you know has been diagnosed with cancer, it can make you feel like your whole world has turned upside down.
Besides the emotional roller coaster, you also have to figure out what your next step is in terms of treatment.
Typically, if you've been diagnosed with cancer, surgery, radiation and chemotherapy are the most utilized treatments.
Unfortunately, with all of these treatments, there are many physical and emotional side effects.
Are there any other potential cancer cures that have limited access?
Listen in as Dr. Craig Dionne joins Dr. Mike to discuss potential cancer treatments that have limited access.
Selected Podcast
Can Cancer Be Cured?
Featured Speaker:
Dr. Craig Dionne has more than 25 years of experience in the pharmaceutical industry, directing drug discovery and drug development.
As chief executive officer at GenSpera, Dr. Dionne directs the organization as a clinical stage pharmaceutical company and its current work developing cutting-edge therapeutics to treat some of the most challenging areas in oncology and urology.
Prior to launching GenSpera in 2003, he served as executive vice president of research and therapeutics at the Prostate Cancer Foundation. As a senior vice president in Discovery Research at Cephalon, Inc., his efforts were instrumental in identifying four different drugs that were brought into clinical evaluation over a span of six years.
Dr. Dionne received his doctorate from the University of Texas in 1984 and trained as a postdoctoral fellow at Dana-Farber Cancer Institute and Harvard Medical School. Dr. Dionne is co-inventor on six issued United States patents and has co-authored more than 50 scientific publications.
Dr. Craig Dionne has more than 25 years of experience in the pharmaceutical industry, directing drug discovery and drug development.As chief executive officer at GenSpera, Dr. Dionne directs the organization as a clinical stage pharmaceutical company and its current work developing cutting-edge therapeutics to treat some of the most challenging areas in oncology and urology.
Prior to launching GenSpera in 2003, he served as executive vice president of research and therapeutics at the Prostate Cancer Foundation. As a senior vice president in Discovery Research at Cephalon, Inc., his efforts were instrumental in identifying four different drugs that were brought into clinical evaluation over a span of six years.
Dr. Dionne received his doctorate from the University of Texas in 1984 and trained as a postdoctoral fellow at Dana-Farber Cancer Institute and Harvard Medical School. Dr. Dionne is co-inventor on six issued United States patents and has co-authored more than 50 scientific publications.